FRMD6 and glioblastoma: To determine how FRMD6 affects GBM growth and progression in vivo, pooled populations of U87MG and U251 cells transduced with empty expression vector or expressing v5-tagged FRMD6 (Figure 2A) were used in the in vivo subcutaneous (s.c.) and intracranial (i.c).